Great insights shared by market leaders at Pharma’s Almanac roundtable discussion. Click HERE to access the full summary.
Roundtable Discussion – Which International Markets Can we Anticipate Significant Developments?
by Jessica Hogan |
-
Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/
-
Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/
-
Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/
-
Jessica Hoganhttps://emergingbiotalk.com/author/jessica-hogan/
Related Posts
Emerging Biotech · mAb, ADC, recombinant
Bridging the Sponsor – CMO Data Gulf
Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…
by Jessica Hogan
mAb, ADC, recombinant
Watch Now: mAbs and ADCs On Demand Event
Click HERE to watch the On Demand Event. Abstracts Building a Successful mAb Platform using the CHOZN® Cell…
by Jessica Hogan
Emerging Biotech · mAb, ADC, recombinant
The Future of Biopharma
The Chemical Engineering magazine has published its third article of the biopharmaceutical manufacturing series, written by David Gemmell….
by David Gemmell
Emerging Biotech · Gene Therapy
Raman analytical monitoring of bioprocesses – a Process Analytical Technology (PAT) solution
Cell culture processes are complex and highly variable in nature and yet only a handful of key parameters…
by Delphine Simiand
mAb, ADC, recombinant
The caking challenge: Are granulated materials a good way to overcome it?
It’s a familiar scenario: opening a package of bulk material that’s been in storage for a while only…
by Thomas Briel
mAb, ADC, recombinant
3 Keys to Virus Risk Mitigation for Biopharmaceuticals
Start Early Developing and manufacturing a biopharmaceutical drug is a complex mission . Throughout development, teams working on…
